Posted on Leave a comment

How Virtual Health Assistants Can Reshape Healthcare

Guest post written by Thomas Morrow

Thomas Morrow, M.D., has 25 years experience across the healthcare industry. He currently serves as an unpaid advisor to Next IT, and a medical director at Genentech.

Advanced data analytics tools, voice recognition and new user interfaces are a few of the technologies buzzing with promise to cure our healthcare system – but all of these new tools overlook a critical stakeholder: The patient.

Providers, payers and physician groups are expected to spend more than $69 billion on healthcare-related IT by 2017. For the most part, solutions designed to improve efficiency have taken center stage.

But making lots of small, incremental efficiency gains in hospitals or physician offices will not be enough to ensure proper care for all those who seek it. Consider this: There’s just one licensed physician for every 370 people in the U.S.

Addressing this problem in a vacuum is not only misguided, it’s unsustainable. The U.S. population will continue to outpace the capacity of the physician community, regardless of the most promising physician-focused technologies.

At the heart of our healthcare crisis is not physician inefficiency – although there is certainly major room for improvement. Our issues go much deeper. It’s time for a different strategy – one that focuses on keeping patients healthy.

Empower the Patient

Healthcare quality organizations, like the National Committee for Quality Assurance suggest that millions of people in the United States do not receive the basic recommendations for preventive health services such as immunizations, pap smears, mammograms, colorectal cancer screenings and the like.

Even more alarming, more than 133 million Americans have at least one chronic illness – from heart disease to diabetes to arthritis – but the estimated medication adherence rate in this group is just 50 percent – costing the U.S. healthcare system between $100 billion and $289 billion annually.

Meanwhile, nearly 40% of doctors say patient non-adherence significantly influences their ability to provide optimal care. Physicians rely on large clinical trials and long-term studies to find the best way to keep populations and individuals with chronic disease healthy over long periods of times.

While physicians prescribe therapy and lifestyle modifications based on these clinical trials, the number of patients who follow the rules, and the percentage of patients who are actually reaching their goals (controlled their blood pressure, cholesterol, diabetes, etc.), is small. That  begs the question: What can we do to increase adherence to healthcare regimens, and where’s the breakdown?

Patients need guideline-driven answers, but they also need someone, or in this case, some thing, to help them stay on track. Patient-centered virtual health assistants, designed to respond to voice or text questions through mobile devices, are our best option to give patients 24/7 access to current information, specific to their age, social setting, likes and dislikes, tastes, financial ability, literacy and culture.

If we don’t directly address the patient need for better information, we’re cultivating a system designed to force patients to rely on physicians for care at every turn. More inefficiency. More physician burden. More spending.

Most experts agree that increasing patient engagement and improving self-management skills for chronic disease will greatly reduce healthcare inefficiencies, but right now, there are limited resources available to patients for around-the-clock guidance, available to answer the 3 a.m. questions.

Our natural opportunity to remove the access barriers, increase patient literacy and greatly improve engagement is to employ technology that enlists patient participation. It’s the only way to sustainably improve the state of healthcare. This is where we need the most help from tech.

Personal Advice: Where and When Needed

To treat a headache, consumers can simply read an aspirin bottle and take the recommended dose. But how do patients handle something more serious – especially if their physician is out of reach?

Effective tools require comprehension of the disease itself, and also patient history. The adoption of mobile, smart devices opened the door for personalized intelligent health assistants that can encourage patient adherence through two-way conversation.

For example, a virtual health assistant that proactively reaches out to the patient when they fail to enter their scheduled insulin injection, or multiple sclerosis medication dose, can help patients to stay on track and troubleshoot potentially precarious situations.

We need the ability for something to assist a patient with diabetes, who also has a five year old with a gluten sensitivity, decide what to cook for dinner. We need an assistant to remind a 70-year-old with early dementia what to do when he forgets his heart pill – double up or just take his next dose early.

We need an assistant to advise a young mother what to do with a child who has a fever. And we need this all to be done in an affordable, scalable manner, through a pervasive and accepted platform.

Custom solutions to tackle specific illnesses, with the ability to analyze personalized information, will create true wellness partners for patients.

Beyond the Check-Up: Better Patient-Physician Communication

There’s another major benefit to VHAs: These tools give healthcare entities a greater understanding of the patient as an individual, offering in-depth insights into behavioral patterns, motivators and indicators. VHAs that integrate with electronic health records allow active monitoring of their patient base, and provide context for deeper, richer conversations.

Caseworkers, specialists, physicians and drug makers are consistently missing opportunities to collaborate, due in large part to logistic barriers. Further complicating the issue, these conversations often happen above the patient, leaving gaps in the flow of information, and patients with more questions than answers.

Caseworkers are under the gun to manage hundreds of patients, but can most likely reach just about 10 percent of them on any given day. Each case, and patient, is unique – and there simply aren’t enough resources to go around. A virtual solution designed to integrate information from each piece of the physician-patient dialog, can give caseworkers the information needed to reach the patients that need them most urgently.

Advanced VHAs have the ability to recognize speech and understand user intent – solving problems at the patient level – addressing the 300 million people who need help with the day-to-day health decisions.

And they bring limitless options to the table. Retail pharmacies can reach out to people not taking their prescribed medication on a recommended basis. Hospitals and physicians can deeply engage patients. Providers can proactively recommend preventive health screenings for cancer.

For the entire healthcare community – from drug maker to case worker – VHAs are our best opportunity to take advantage of a technology that can truly impact the long-term wellbeing of patients.

Posted on Leave a comment

Two Paths to the Gradual Abolition of Smoking via NYTimes.com

Stubbing Out Cigarettes for Good

By RICHARD A. DAYNARD,  Published: March 3, 2013

Fewer than one in five American adults smoke, a share that’s plunged by about half since the 1960s — an achievement due, in some measure, to Dr. Koop’s antismoking crusade as surgeon general, from 1981 to 1989. Revelations in the 1990s about tobacco companies’ cover-up of smoking’s dangers also played a role. So have a host of other strategies that have included consumer taxes, minimum ages for cigarette purchases, restrictions on smoking in public spaces and programs to help people quit. Continuing on the same path, with some luck, we might be able reduce the smoking rate a little more.

But that would still leave us with a profound public health tragedy: cigarettes continue to kill more than 400,000 Americans a year and cost untold billions in health care spending.

To its credit, the Food and Drug Administration has tried more aggressive approaches, including a recent effort to require hard-hitting graphic warnings on cigarette packages. That proposal, already the rule in dozens of countries, has been held up in United States federal courts over concerns that the ads might infringe on cigarette manufacturers’ First Amendment rights. But even if implemented, more scare tactics would not go far enough.

What we need is an all-out push to reduce smoking rates to well below 10 percent. The notion is nothing new to tobacco-control advocates, many of whom gathered last week in Cambridge, Mass., for a conference on the governance of tobacco, sponsored by Harvard with support from the World Health Organization.

But outside of such academic meetings and journals, little has been said about two possible approaches that could have an immediate impact.

One involves federal action; the other, state or local action. Both are made possible by the Family Smoking Prevention and Tobacco Control Act, which President Obama signed in June 2009.

Under the act, the F.D.A. has the power to establish tobacco product standards including “provisions, where appropriate, for nicotine yields of the product.” The only limitation on this power is that the F.D.A. may not require that nicotine yields be reduced to zero. The law calls on the F.D.A. to apply public health criteria — “the risks and benefits to the population as a whole” — in designing its regulations. It also encourages the F.D.A. to create tobacco standards that will help existing users stop smoking and decrease the risk that nonsmokers will start.

The F.D.A. would be well within its authority to require nicotine content to be below addictive levels — an idea that originated with a 1994 article in The New England Journal of Medicine urging a nonaddictive nicotine standard.

Cigarette makers would lobby hard to block such a standard. But if the F.D.A. insisted on the change, and cigarettes ceased to be addictive, ample evidence shows that most smokers would quit or switch to less toxic nicotine products. Current nonsmokers, moreover, would be far less likely to become addicted.

Another part of the act affirms the authority of states and municipal governments to prohibit the sale, distribution and possession of — and even access and exposure to — tobacco products by individuals of any age.

This provides an opportunity for states, counties and cities to adopt the Smokefree Generation, a proposal by A. J. Berrick, a mathematics professor in Singapore.

The idea is simple: no one born in or after 2000 can ever be sold cigarettes. Under such legislation, which jurisdictions like the Australian state of Tasmania are considering, the vast majority of this cohort — the oldest are now 13 — would never begin smoking. It’s hard to imagine too many parents objecting, and it would be easy for retailers to enforce. In the United States, it would provide a useful focus for state and local public health officials to do something game-changing, rather than sitting on the sidelines waiting for Washington to act.

Critics will say that, even if a state or city passed such a law, would-be smokers could go to an adjoining one to buy cigarettes. But evidence suggests that border-crossing and smuggling would be minimal. States that have sharply raised their cigarette taxes, after all, have not only increased tax revenue but also reduced rates of smoking prevalence, even among nicotine addicts. Young people, who are generally not addicted (yet) and who tend not to have peers who smoke, are even less likely to chase cigarettes across state or county lines.

Some antismoking advocates who support existing approaches (smoking-cessation programs, higher taxes) fear that pushing for an “end game” — a smoking rate below 10 percent — is too ambitious. But then, banning smoking in restaurants, workplaces and bars was once seen as crazy, too. Sometimes, a little crazy goes a long way.

Richard A. Daynard is a professor of law at Northeastern University and president of its Public Health Advocacy Institute.

Posted on 14 Comments

Bitter Pill: Why Medical Bills Are Killing Us via TIME.com

Bitter Pill: Why Medical Bills Are Killing Us

 

 

brill.pill9.indd

1. Routine Care, Unforgettable Bills

When Sean Recchi, a 42-year-old from Lancaster, Ohio, was told last March that he had non-Hodgkin’s lymphoma, his wife Stephanie knew she had to get him to MD Anderson Cancer Center in Houston. Stephanie’s father had been treated there 10 years earlier, and she and her family credited the doctors and nurses at MD Anderson with extending his life by at least eight years.

Because Stephanie and her husband had recently started their own small technology business, they were unable to buy comprehensive health insurance. For $469 a month, or about 20% of their income, they had been able to get only a policy that covered just $2,000 per day of any hospital costs. “We don’t take that kind of discount insurance,” said the woman at MD Anderson when Stephanie called to make an appointment for Sean.

Stephanie was then told by a billing clerk that the estimated cost of Sean’s visit — just to be examined for six days so a treatment plan could be devised — would be $48,900, due in advance. Stephanie got her mother to write her a check. “You do anything you can in a situation like that,” she says. The Recchis flew to Houston, leaving Stephanie’s mother to care for their two teenage children.

About a week later, Stephanie had to ask her mother for $35,000 more so Sean could begin the treatment the doctors had decided was urgent. His condition had worsened rapidly since he had arrived in Houston. He was “sweating and shaking with chills and pains,” Stephanie recalls. “He had a large mass in his chest that was … growing. He was panicked.”

Nonetheless, Sean was held for about 90 minutes in a reception area, she says, because the hospital could not confirm that the check had cleared. Sean was allowed to see the doctor only after he advanced MD Anderson $7,500 from his credit card. The hospital says there was nothing unusual about how Sean was kept waiting. According to MD Anderson communications manager Julie Penne, “Asking for advance payment for services is a common, if unfortunate, situation that confronts hospitals all over the United States.”

Sean Recchi

Claudia Susana for TIME

Sean Recchi
Diagnosed with non-Hodgkin’s lymphoma at age 42. Total cost, in advance, for Sean’s treatment plan and initial doses of chemotherapy: $83,900. Charges for blood and lab tests amounted to more than $15,000; with Medicare, they would have cost a few hundred dollars

The total cost, in advance, for Sean to get his treatment plan and initial doses of chemotherapy was $83,900.

Why?

The first of the 344 lines printed out across eight pages of his hospital bill — filled with indecipherable numerical codes and acronyms — seemed innocuous. But it set the tone for all that followed. It read, “1 ACETAMINOPHE TABS 325 MG.” The charge was only $1.50, but it was for a generic version of a Tylenol pill. You can buy 100 of them on Amazon for $1.49 even without a hospital’s purchasing power.

(In-Depth VideoThe Exorbitant Prices of Health Care)

Dozens of midpriced items were embedded with similarly aggressive markups, like $283.00 for a “CHEST, PA AND LAT 71020.” That’s a simple chest X-ray, for which MD Anderson is routinely paid $20.44 when it treats a patient on Medicare, the government health care program for the elderly.

Every time a nurse drew blood, a “ROUTINE VENIPUNCTURE” charge of $36.00 appeared, accompanied by charges of $23 to $78 for each of a dozen or more lab analyses performed on the blood sample. In all, the charges for blood and other lab tests done on Recchi amounted to more than $15,000. Had Recchi been old enough for Medicare, MD Anderson would have been paid a few hundred dollars for all those tests. By law, Medicare’s payments approximate a hospital’s cost of providing a service, including overhead, equipment and salaries.

On the second page of the bill, the markups got bolder. Recchi was charged $13,702 for “1 RITUXIMAB INJ 660 MG.” That’s an injection of 660 mg of a cancer wonder drug called Rituxan. The average price paid by all hospitals for this dose is about $4,000, but MD Anderson probably gets a volume discount that would make its cost $3,000 to $3,500. That means the nonprofit cancer center’s paid-in-advance markup on Recchi’s lifesaving shot would be about 400%.

When I asked MD Anderson to comment on the charges on Recchi’s bill, the cancer center released a written statement that said in part, “The issues related to health care finance are complex for patients, health care providers, payers and government entities alike … MD Anderson’s clinical billing and collection practices are similar to those of other major hospitals and academic medical centers.”

The hospital’s hard-nosed approach pays off. Although it is officially a nonprofit unit of the University of Texas, MD Anderson has revenue that exceeds the cost of the world-class care it provides by so much that its operating profit for the fiscal year 2010, the most recent annual report it filed with the U.S. Department of Health and Human Services, was $531 million. That’s a profit margin of 26% on revenue of $2.05 billion, an astounding result for such a service-intensive enterprise.1

The president of MD Anderson is paid like someone running a prosperous business. Ronald DePinho’s total compensation last year was $1,845,000. That does not count outside earnings derived from a much publicized waiver he received from the university that, according to the Houston Chronicle, allows him to maintain unspecified “financial ties with his three principal pharmaceutical companies.”

DePinho’s salary is nearly triple the $674,350 paid to William Powers Jr., the president of the entire University of Texas system, of which MD Anderson is a part. This pay structure is emblematic of American medical economics and is reflected on campuses across the U.S., where the president of a hospital or hospital system associated with a university — whether it’s Texas, Stanford, Duke or Yale — is invariably paid much more than the person in charge of the university.

I got the idea for this article when I was visiting Rice University last year. As I was leaving the campus, which is just outside the central business district of Houston, I noticed a group of glass skyscrapers about a mile away lighting up the evening sky. The scene looked like Dubai. I was looking at the Texas Medical Center, a nearly 1,300-acre, 280-building complex of hospitals and related medical facilities, of which MD Anderson is the lead brand name. Medicine had obviously become a huge business. In fact, of Houston’s top 10 employers, five are hospitals, including MD Anderson with 19,000 employees; three, led by ExxonMobil with 14,000 employees, are energy companies. How did that happen, I wondered. Where’s all that money coming from? And where is it going? I have spent the past seven months trying to find out by analyzing a variety of bills from hospitals like MD Anderson, doctors, drug companies and every other player in the American health care ecosystem.

When you look behind the bills that Sean Recchi and other patients receive, you see nothing rational — no rhyme or reason — about the costs they faced in a marketplace they enter through no choice of their own. The only constant is the sticker shock for the patients who are asked to pay.

(iReport: Tell Us Your Health Care Story)

Gauze Pads

Photograph by Nick Veasey for TIME

Gauze Pads: $77
Charge for each of four boxes of sterile gauze pads, as itemized in a $348,000 bill following a patient’s diagnosis of lung cancer

Yet those who work in the health care industry and those who argue over health care policy seem inured to the shock. When we debate health care policy, we seem to jump right to the issue of who should pay the bills, blowing past what should be the first question: Why exactly are the bills so high?

What are the reasons, good or bad, that cancer means a half-million- or million-dollar tab? Why should a trip to the emergency room for chest pains that turn out to be indigestion bring a bill that can exceed the cost of a semester of college? What makes a single dose of even the most wonderful wonder drug cost thousands of dollars? Why does simple lab work done during a few days in a hospital cost more than a car? And what is so different about the medical ecosystem that causes technology advances to drive bills up instead of down?

Recchi’s bill and six others examined line by line for this article offer a closeup window into what happens when powerless buyers — whether they are people like Recchi or big health-insurance companies — meet sellers in what is the ultimate seller’s market.

The result is a uniquely American gold rush for those who provide everything from wonder drugs to canes to high-tech implants to CT scans to hospital bill-coding and collection services. In hundreds of small and midsize cities across the country — from Stamford, Conn., to Marlton, N.J., to Oklahoma City — the American health care market has transformed tax-exempt “nonprofit” hospitals into the towns’ most profitable businesses and largest employers, often presided over by the regions’ most richly compensated executives. And in our largest cities, the system offers lavish paychecks even to midlevel hospital managers, like the 14 administrators at New York City’s Memorial Sloan-Kettering Cancer Center who are paid over $500,000 a year, including six who make over $1 million.

Taken as a whole, these powerful institutions and the bills they churn out dominate the nation’s economy and put demands on taxpayers to a degree unequaled anywhere else on earth. In the U.S., people spend almost 20% of the gross domestic product on health care, compared with about half that in most developed countries. Yet in every measurable way, the results our health care system produces are no better and often worse than the outcomes in those countries.

According to one of a series of exhaustive studies done by the McKinsey & Co. consulting firm, we spend more on health care than the next 10 biggest spenders combined: Japan, Germany, France, China, the U.K., Italy, Canada, Brazil, Spain and Australia. We may be shocked at the $60 billion price tag for cleaning up after Hurricane Sandy. We spent almost that much last week on health care. We spend more every year on artificial knees and hips than what Hollywood collects at the box office. We spend two or three times that much on durable medical devices like canes and wheelchairs, in part because a heavily lobbied Congress forces Medicare to pay 25% to 75% more for this equipment than it would cost at Walmart.

The Bureau of Labor Statistics projects that 10 of the 20 occupations that will grow the fastest in the U.S. by 2020 are related to health care. America’s largest city may be commonly thought of as the world’s financial-services capital, but of New York’s 18 largest private employers, eight are hospitals and four are banks. Employing all those people in the cause of curing the sick is, of course, not anything to be ashamed of. But the drag on our overall economy that comes with taxpayers, employers and consumers spending so much more than is spent in any other country for the same product is unsustainable. Health care is eating away at our economy and our treasury.

The health care industry seems to have the will and the means to keep it that way. According to the Center for Responsive Politics, the pharmaceutical and health-care-product industries, combined with organizations representing doctors, hospitals, nursing homes, health services and HMOs, have spent $5.36 billion since 1998 on lobbying in Washington. That dwarfs the $1.53 billion spent by the defense and aerospace industries and the $1.3 billion spent by oil and gas interests over the same period. That’s right: the health-care-industrial complex spends more than three times what the military-industrial complex spends in Washington.

When you crunch data compiled by McKinsey and other researchers, the big picture looks like this: We’re likely to spend $2.8 trillion this year on health care. That $2.8 trillion is likely to be $750 billion, or 27%, more than we would spend if we spent the same per capita as other developed countries, even after adjusting for the relatively high per capita income in the U.S. vs. those other countries. Of the total $2.8 trillion that will be spent on health care, about $800 billion will be paid by the federal government through the Medicare insurance program for the disabled and those 65 and older and the Medicaid program, which provides care for the poor. That $800 billion, which keeps rising far faster than inflation and the gross domestic product, is what’s driving the federal deficit. The other $2 trillion will be paid mostly by private health-insurance companies and individuals who have no insurance or who will pay some portion of the bills covered by their insurance. This is what’s increasingly burdening businesses that pay for their employees’ health insurance and forcing individuals to pay so much in out-of-pocket expenses.

1. Here and elsewhere I define operating profit as the hospital’s excess of revenue over expenses, plus the amount it lists on its tax return for depreciation of assets—because depreciation is an accounting expense, not a cash expense. John Gunn, chief operating officer of Memorial Sloan-Kettering Cancer Center, calls this the “fairest way” of judging a hospital’s financial performance

Read more: http://healthland.time.com/2013/02/20/bitter-pill-why-medical-bills-are-killing-us/#ixzz2LvujinVc

 

Posted on Leave a comment

Better, if Not Cheaper, Care for the Dying

Ezekiel J. Emanuel

Ezekiel J. Emanuel on health policy and other topics.

IT is conventional wisdom that end-of-life care is an increasingly huge proportion of health care spending. I’ve often heard it said that people spend more on health care in the year before they die than they do in the entire rest of their lives. If we don’t address these costs, the story goes, we can never control health care inflation.

Wrong. Here are the real numbers. The roughly 6 percent of Medicare patients who die each year do make up a large proportion of Medicare costs: 27 to 30 percent. But this figure has not changed significantly in decades. And the total number of Americans, not just older people, who die every year — less than 1 percent of the population — account for much less of total health care spending, just 10 to 12 percent.

MSMDNYC

The more important issue is that just because we spend a lot on end-of-life care does not mean we can save a lot. We do know that costs for dying patients vary widely among hospitals, which suggests that we can do better. And yet no one can reliably say what specific changes would significantly lower costs. There is no body of well-conducted research studies that has proved how to save 5, 10, much less 20 percent.

Recent studies find that hospice may reduce costs in the last year of life for cancer patients by 10 to 20 percent. But they find no savings from hospice care for patients who die of other conditions, like emphysema or heart failure. No one is sure why hospice care doesn’t save more. It may be because patients are enrolled in hospice care too late, or because hospice services themselves are labor-intensive and not cheap.

Even if we can never save a dime, however, there are good reasons to think about changing end-of-life care practices. While end-of-life care has improved considerably over the last 30 years, many Americans still die in hospitals when they would rather die at home. Nearly 20 percent of deaths occur in an intensive care unit or immediately after discharge, and too many patients experience symptoms like pain that are controllable with appropriate palliative care.

Here are four things the health care system should do to try to improve care for the dying, even if they won’t save money.

First, all doctors and nurses should be trained in how to talk to patients and families about end-of-life care. When I was starting out, I was lucky enough to be able to witness how a great oncologist communicated with patients and their families when it was clear they were going to die, but I received no formal training whatsoever. It is hard to improve care for the dying if health professionals don’t know how to talk about it. Fortunately, there are excellent communication techniques and training programs available — they don’t have to be invented from scratch.

A related intervention — an idea that never actually was in the Affordable Care Act but inspired the death panel accusation — is that physicians should be paid a one-time fee to talk with patients about their preferences for end-of-life care. Even if physicians are well trained in communication, these conversations take time and are emotionally draining. This should be recognized through compensation.

Third, every hospital should be required to have palliative care services available both in the hospital and at the homes of dying patients who are discharged. Over 40 percent of hospitals with more than 50 beds do not have palliative care services. And we don’t know how many actually have palliative care services once patients are sent home. These services should be delivered by trained experts in diagnosing and managing common symptoms of the dying, like pain, nausea, insomnia, shortness of breath, fatigue and depression.

Finally, we need to revise eligibility for hospice care. Right now doctors must certify that patients have six months or less to live and patients must agree to forgo life-sustaining treatments. The decision about whether to put a patient in hospice care should not be based on unreliable predictions about how long he has left to live but rather on his needs for specialized care, like morphine infusions.

These changes could be made in at least two ways. The Joint Commission — the nonprofit group that certifies health care organizations — could make training physicians and nurses to talk about end-of-life care and having palliative care available a requirement for hospital accreditation. Alternatively, Medicare, private insurers and, after 2014, state exchanges could require hospitals to provide communication training and palliative services as a condition for payment.

Unfortunately, there is no evidence that these interventions will save money. And I can’t definitively prove they will make the care of dying patients better. But doing nothing to try to help the dying when the rest of the health care system is improving care is not an option.

A version of this article appeared in print on 01/04/2013, on page A23 of the NewYork edition with the headline: Better, if Not Cheaper, Care.

Posted on Leave a comment

Health Care Reform Lives: What Obama Must Do To Ensure It Thrives

President Barack Obama’s reelection removes questions about the survival of the health care reform law bearing his name, meaning that over the next two years medical insurance will all but certainly be extended to as many as 30 million Americans who now lack coverage.

But even as the endurance of Obamacare no longer appears in doubt, the breadth and impact of the president’s signature health care expansion remains subject to the vagaries of Washington bureaucracy, the inclinations of private employers opposed to extending health care benefits, and the political calculations of elected officials in individual states. Republican governors in six states have vowed to oppose one of health care reform’s central components — a dramatic expansion of Medicaid, the joint federal-state insurance program for poor people.

In essence, Tuesday night’s election result replaced one giant threat to Obamacare — the prospect that the president’s Republican challenger, Mitt Romney, would seek to repeal it — with myriad smaller questions: Will the federal agencies tasked with writing the rules to implement it do their work quickly enough, and despite the lobbying by affected industries seeking favored treatment? Will states opposed to Obamacare limit its reach by refusing federal money that is supposed to finance the Medicaid expansion?

With his reelection secured, it’s now up to Obama to turn those question marks into periods. Failure to do so could jeopardize the entirety of his project, leaving Americans still clamoring for stable and affordable health care disappointed and angry. Success might enshrine him as the president who delivered largest expansion of the social safety net since the Great Society.

“There are going to be some glitches,” said Timothy Jost, a professor at the Washington and Lee University School of Law who advises state and federal officials as a consumer representative to the National Association of Insurance Commissioners. “The implementation of massive programs is always problematic,” he said. “I’m fairly optimistic that this is going to happen. I’m also very optimistic that once it’s been in place a year or two, a lot of people are going to say, ‘How did we ever live without this?'”

In simplest terms, Obamacare amounts to a package of measures that significantly expands options for Americans who now lack health care coverage. The law guarantees health benefits for the poorest Americans by expanding Medicaid to anyone who earns up to 133 percent of the federal poverty level, which is $14,856 this year. Currently, states determine their own Medicaid eligibility levels — though federal minimums apply –and many exclude people once incomes reach as little as half the federal poverty line.

Among those with incomes reaching up to 400 percent of poverty — or $44,680 in 2012 — the federal government will extend tax credits aimed at enabling people to buy their own health insurance policies from providers, shopping for their plans on so-called exchanges that allow them to compare prices and benefits.

 

Not least, Obamacare prohibits some of the health insurance industry’s most notorious practices, such as denying coverage to people who have pre-existing conditions, charging women higher premiums than men, and cutting customers off when their medical bills pile up.

In the nearly three years since his proposed legislation became law, Obamacare has already survived unanimous opposition from Republicans, a Supreme Court challenge, and finally Romney’s vow to undo the law if elected.

With these threats duly vanquished, the health care reform law now confronts a diffuse state-by-state, bureaucrat-by-bureaucrat battle to reach the ordinary Americans hoping for health care coverage.

Some of its measures have already been implemented, such as a requirement that insurance plans allow parents to cover adult children up to 26 years old on their policies. A prohibition against rejecting children with pre-existing conditions is also in place.

But the Obama administration has yet to publish a slew of crucial regulations that will define how health insurance is sold and what it must cover.

Health insurance companies must rush to adapt to a new market and employers will weigh covering workers or dropping health benefits to save money.

And as the Obama administration seeks to navigate this thicket of challenges, it still finds itself grappling with a public that is far from unified and not fully sold on the merits of his reform scheme, as Election Day exit polls revealed.

The biggest obstacle facing successful implementation of Obama’s Affordable Care Act is the law’s reliance on states to carry out one vital component of the law, the Medicaid expansion. While the Supreme Court upheld the broad challenge to Obamacare, finding that the federal government has the power to require people to purchase insurance, it also struck down a provision that obligated states to particpate in adding millions of people to their Medicaid rolls. That means the administration will need to cajole individual governors to go along to have any hope of achieving its goal of near-universal coverage by expanding health insurance to an estimated 30 million uninsured people by 2022.

“The major implementation tasks associated with the law are carried out by the states, especially when it comes to extending health insurance coverage,” said Alan Weil, the executive director of th
e National Academy for State Health Policy.

Republican governors like Florida’s Rick Scott and Texas’ Rick Perry have adamantly refused to extend health coverage to poor residents in their states, which will limit health care reform’s impact on the neediest people.

The stakes are considerable: The Congressional Budget Office calculated that allowing states to opt out of the planned Medicaid expansion could leave some 3 million people uninsured.

Republican recalcitrance and uncertainty about the federal rules have limited states’ readiness to carry out the law. As evidence of the intensity of opposition to Obamacare in some quarters, Alabama, Missouri, Montana and Wyoming voters all backed ballot initiatives Tuesday aiming to limit their states’ ability to comply with the law. A similar measure failed in Florida.

The decisions states make will go a long way toward determining how many poor people gain health coverage because they also have the option of creating their own health insurance exchanges under federal guidelines and have broad leeway to set regulations on health insurance benefits and premiums.

A deadline looms just 10 days away for states to present the administration with their plans for building the health insurance exchanges. According to the consulting company Avalere Health, 20 states are likely to run their own exchanges and 13 are likely to partner with the federal government, leaving federal authorities to manage the remainder.

Private sector interests that opposed health care reform, in whole or in part, will have to set aside their objections and adjust to the new reality if the law is to reach as many uninsured people as Obama aims.

Health insurance companies stand to gain tens of millions of new customers, but face new regulations and a new tax on their sales that will cut into their profits. A statement issued Wednesday by Karen Ignagni, president and CEO of America’s Health Insurance Plans, a trade group, underscores insurers’ mixed view of Obamacare.

“As the health care reform law is implemented, policymakers must prioritize affordability for consumers and employers. Several provisions in the law, such as the new premium tax, minimum coverage requirements, and age rating restrictions, need to be addressed to keep coverage as affordable as possible and ensure broad participation in the system,” Ignagni said.

Possibly the biggest source of potential disruption in the health insurance market could occur in plans offered to workers by their employers. More about 150 million Americans are enrolled in job-based health benefits, making it the most common source of coverage. That won’t change, said Tracy Watts, the national health care reform leader for the consulting firm Mercer.

“Over 90 percent of employers are committed to continuing to offer coverage in 2014,” Watts said, citing the company’s surveys, which are consistent with projections from the Congressional Budget Office and others, and the real-word experience from Romney’s similar 2006 Massachusetts health care law.

Under health care reform, companies with at least 50 employees must provide coverage or face penalties. For smaller companies, paying a penalty and letting workers buy their own coverage on the exchanges might make more sense, Watts said. The biggest cost increases will hit retailers and other companies that typically don’t cover their workers, she said.

Reform

Posted on Leave a comment

In Praise of Pumpkins via Real Life Nutrition

By Janet Helm, MS, RD

It’s that time of year when pumpkins get their due. But these orange-fleshed gourds are so much more than seasonal décor or pie filling. Pumpkins are nutritional powerhouses, so I’m thrilled to see such enthusiasm for this fall icon.

Folks have become so enamored with pumpkin that some trend trackers have called it the new bacon. That’s because pumpkin is showing up everywhere. It’s starting to achieve bacon-like ubiquity. The firm Dataessential says more than 60 pumpkin-related dishes are now on the menus of America’s top 250 chains, and this year is on track to be one of the most active years for seasonal pumpkin menuing.  Pumpkin drink offerings have increased 400 percent during the past five years – although you’ll typically only find pumpkin spice flavorings and not the vegetable itself.

I’ve certainly noticed the pumpkin trend on Healthy Aperture, the online food photo gallery I helped created with fellow food blogger Regan Jones. Contributors have gone crazy with creative pumpkin recipes, including pumpkin mac and cheese, ravioli, chili, soup, enchiladas, risotto, granola, pancakes, waffles, oatmeal, doughnuts, pumpkin butter, gelato, cake, cheesecake shooters and smoothies.  You’ll also find interesting ideas for roasting pumpkin seeds, also called pepitas.

It’s a good thing that pumpkin is gaining in popularity. We need to be eating more orange-hued vegetables. The color is an indicator of lots of carotenoids, including beta carotene, which our body converts to vitamin A. Pumpkin is also rich in vitamin C, fiber, and potassium (one of the nutrients most likely to be lacking in the American diet.) You’ll also find the compounds lutein and zeaxanthin, which are good for our eyes.

Canned pumpkin can be used in lots of ways beyond pie – stirred into muffins, quick breads, and pancakes or added to soups, risottos, and pasta dishes. You can also easily make your own pumpkin puree. That way you can control the amount of sugar that’s used.

Yet, one of my favorite ways to enjoy pumpkin is roasted. Cutting a pumpkin is not just for Jack O’Lanterns. Once you remove the seeds (save those for roasting) and the hard outer shell, pumpkin is delicious roasted with a drizzle of olive oil and a sprinkling of sea salt and spices, such as cinnamon or cayenne. But don’t stop there. Check out other winter squashes, such as butternut, acorn, delicata, turban, hubbard, kabocha, and spaghetti squash (which has a stringy flesh that makes a great stand-in for pasta). Don’t be intimidated by their thick, gnarly skins and funny names. These are wondrous vegetables to get to know.

Remember, we need to fill half our plates with vegetables and fruits. Yet, few Americans are actually meeting daily vegetable guidelines. We’re not eating enough, and we’re not varying our veggies. MyPlate recommends 4-6 cups of orange-red vegetables every week. Pumpkin, a uniquely American vegetable, is a good place to start.

Pumpkins-squash-gourds

 

Posted on Leave a comment

One Scary Fact: Just One More Reason for Healthcare Reform Laws

P2550

Posted on Leave a comment

How to Fend Off a Food Craving (and new research on the 'body knows what it wants' theory)

A cupcake is calling you.

You can practically taste the sweet, creamy goodness. You want it so badly you can’t think of anything else. But is it really the taste you crave—or the pleasant associations it brings? Or do you crave it partly because you know you shouldn’t have it? Will fighting the urge make it go away or only make it worse?

Why do people crave certain foods at certain times? There’s a surge of research in this field as scientists try to understand the complex relationships among food, mood, and behavior. Melinda Beck has details on The News Hub. Photo: Getty Images.

Scientists are exploring all these questions as they seek to understand food cravings. The research is taking on new urgency with the nation’s obesity epidemic, since cravings are widely believed to influence snacking behavior, binge eating and bulimia.

Among the findings so far:

Food cravings activate the same reward circuits in the brain as cravings for drugs or alcohol, according to functional MRI scans, tests that measure brain activity by detecting changes in blood flow.

Nearly everyone has food cravings occasionally, but women report having them more often than men, and younger people crave sweets more than older people do.

In one study, 85% of men said they found giving in to food craving satisfying; of women, only 57% said they did.

While many women report craving salt, fat or bizarre combinations of food during pregnancy, researchers can’t find much scientific validation. They suspect folklore and the power of suggestion instead.

What We Crave

Getty Images

 

For decades, researchers surmised that food cravings were the body’s subconscious effort to correct nutritional deficiencies. Longing for steak could indicate a need for protein or iron, according to this theory. Chocoholics might be low on magnesium or other mood-altering chemicals that chocolate contains, including phenylethylamine, a compound humans produce when they’re in love.

But a growing body of research casts doubt on the nutritional-deficiency notion. After all, few people crave vitamin-rich green leafy vegetables and many other foods contain more phenylalanine than chocolate—including salami and cheddar cheese.

Instead, studies show that food cravings involve a complex mix of social, cultural and psychological factors, heavily influenced by environmental cues. While chocolate is consistently the most-craved food in North America, Japanese women are more likely to crave sushi, a recent study found. And only 1% of young Egyptian men and 6% of young Egyptian women reported craving chocolate, according to a 2003 survey. “Many other languages don’t have a word for ‘craving.’ The concept seems to be uniquely important in American culture,” says psychologist Julia Hormes at the University at Albany.

In the U.S., about 50% of women who crave chocolate say their cravings peak around the onset of their monthly period. But researchers haven’t found any correlation between food cravings and hormone levels, and postmenopausal women don’t report a big drop in chocolate cravings, a 2009 survey found. Some psychologists suspect that women may be “self-medicating,” because sweets and carbohydrates spur release of serotonin and other feel-good brain chemicals.

A study of 98 female students at the University of Pennsylvania last year found that those who reported the most cycle-related cravings also had a history of dieting, eating disorders and high body mass indexes. “These seem to be women who think, ‘I shouldn’t have any chocolate at all,’ but then they give in and have the whole bar,” says Dr. Hormes, who led much of the U. Penn research. “The more they try to restrict it, the more they craved it.”

Typically, people crave foods they enjoy—but not always. “It’s possible to like a food without craving it, and crave a food without liking it,” says Marcia Pelchat, a food psychologist at the Monell Chemical Senses Center, a research facility in Philadelphia.

Getty Images

Too many sweets can flood the brain’s reward circuits, causing constant cravings.

In one 2004 study she conducted, a group of subjects consumed only vanilla-flavor Boost, a protein drink, for five days to assess their cravings for other food. She was amazed to find many of them craved Boost after returning to a regular diet: “We thought they’d never want to see it again.”

The same phenomenon occurs with movie-theater popcorn, Dr. Pelchat says: “Most people will admit it’s not the world’s best popcorn, but if the line is long and you’re not able to buy it, you may well crave it.”

Functional MRI scans by Dr. Pelchat showed that sensory memory food cravings activate the same parts of the brain that drug and alcohol cravings do, including the hippocampus, which helps store memories; the insula, involved in perception and emotion; and the caudate, which is important for learning and memory. The circuit is driven by dopamine, the neurotransmitter responsible for reward-driven learning.

Experts say that cravings are fine on occasion—say, for pumpkin pie at Thanksgiving, gingerbread at Christmas or for healthy choices year-round. But indulging too often can send cravings spiraling out of control.

 

Brain researchers have documented that when people continually bombard their reward circuits with drugs, alcohol or high-fat, high-sugar foods, many of the dopamine receptors in the system shut down to prevent overload. And with fewer dopamine receptors at work, the system craves more and more, insatiably. “Pretty soon, one cupcake doesn’t do it anymore. You have to overstuff yourself and you still don’t get that reward,” says Pam Peeke, a physician and author of the new book, “The Hunger Fix.” She notes that food addiction creates changes in the prefrontal cortex, which normally override impulsivity and addictive urges.

What is the best way to fight food cravings? Many studies have shown that the more subjects try to restrict a food, the more they may crave it. So some experts suggest embracing and controlling the urge instead.

One 2003 study at University College in London found that subjects who ate chocolate only in the middle of a meal or just after were more successful at giving it up than those who ate it on an empty stomach.

Cognitive behavior therapy can also be helpful. Researchers in Adelaide, Australia, gave 110 self-professed chocolate cravers each a bag of chocolates to carry around for a week, and instructed half of them in “cognitive restructuring”—challenging their thoughts about chocolate—while the other half learned “cognitive defusion”—accepting and observing their thoughts without acting on them. At the end, the defusion group had three times as much chocolate left than the other group.

Exercise can also cut food cravings. Women who walked briskly on a treadmill for 45 minutes had far less brain response to food images, according to a new study from Brigham Young University in Provo, Utah, published in the journal Medicine & Science in Sports & Exercise.

Other forms of distraction include chewing gum and smelling a nonfood item. Taking a deep whiff of jasmine, for example, helps occupy the same aroma receptors that are a key part of food cravings.

Dr. Peeke suggests setting a timer for 30 minutes whenever a craving comes on. Busy yourself with something else until the timer goes off. The craving may have passed. “If you can at least delay eating the craved food, you can weaken the habitual response,” agrees Dr. Pelchat.

The good news: The longer people stave off their food cravings, studies show, the weaker the urges become.

Write to Melinda Beck at HealthJournal@wsj.com

A version of this article appeared September 18, 2012, on page D1 in the U.S. edition of The Wall Street Journal, with the headline: How to Fend Off a Food Craving.

Craving-saidaonline